Kim Stratton, Founder of Orphazyme

Latest round: Series C. Kim Stratton was appointed Chief Executive Officer of Orphazyme A/S, a biopharmaceutical company.

About Kim Stratton

Kim Stratton was appointed Chief Executive Officer of Orphazyme A/S, a biopharmaceutical company, taking up her position on October 1, 2019. She has more than 25 years of global commercial experience in biopharmaceuticals, with previous roles at Shire Pharmaceuticals and Novartis.

Kim Stratton at a glance

More founders in Copenhagen, Denmark (44)

Browse related founder lists (2)

Full founder directory · Investor directory · Company funding database · Fundraising library